alpha tocopherol/inflammation

TECHNICAL FIELD The present invention relates to novel and useful L-ascorbic acid-2-O-maleic acid-.alpha.-tocopherol diester.1-propanol adduct or pharmacologically acceptable salts of the same, to processes for producing the same and to uses of the same as a cosmetic component or ingredient,

TECHNICAL FIELD This invention generally relates to non-alpha-tocopherol compositions such as gamma-tocopherol, beta-tocopherol or delta-tocopherol, and/or metabolite(s) thereof, and methods for treating and/or ameliorating the symptoms of inflammation in a mammalian subject. The invention also

The present invention relates in general terms to the use of a tocopherol phosphate or an ester or salt thereof for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, having an anti-allergic or anti-inflammatory activity or intended for the prevention

The present invention relates in general terms to the use of a tocopherol phosphate or an ester or salt thereof for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, having an anti-allergic or anti-inflammatory activity or intended for the prevention

The present invention relates in general terms to the use of an .alpha.-tocopherol phosphate, or an ester thereof, or a salt of these compounds, for preparing pharmaceutical, cosmetic or dermatological compositions with antiallergic or antiinflammatory activity or for the prevention or treatment of

The present invention relates in general terms to the use of an .alpha.-tocopherol phosphate, or an ester thereof, or a salt of these compounds, for preparing pharmaceutical, cosmetic or dermatological compositions with antiallergic or antiinflammatory activity or for the prevention or treatment of

The present invention relates in general terms to the use of an .alpha.-tocopherol phosphate, or an ester thereof, or a salt of these compounds, for preparing pharmaceutical, cosmetic or dermatological compositions with antiallergic or antiinflammatory activity or for the prevention or treatment of

FIELD OF INVENTION The present invention relates to the use of a composition comprising dihydroquercetin, as well as optionally .alpha.-tocopherol and/or bisabolol for treating the effects associated with skin inflammatory disorder, such as those associated with diseases characterized by

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to the clinical treatment of chronic inflammatory disorders. For purposes of this invention, the category of chronic inflammatory disorders includes chronic gingivitis, chronic periodontitis, chronic autoimmune gastritis,

The present invention illustrates a new use for the known natural lipid ethyl linoleate [ethyl-cis,cis(9,12)-octadecadienoate]. This compound, with adequate food grade antioxidants or stabilizers, has been previously utilized in burn therapy to diminish water loss through the skin with a critical

FIELD OF INVENTION The invention relates to biologically active agents from vegetable raw material and can be used in complex therapy of different inflammatory diseases as well as an agent increasing non-specific resistance of the organism. PRIOR ART Modern anti-inflammatory agents are represented

FIELD OF THE INVENTION The present invention relates generally to topically applicable pharmaceutical and cosmetic compositions, and more particularly, to compositions containing specific mixtures of amino acids and vitamins. BACKGROUND OF THE INVENTION The stratum corneum or horny layer of the

RELATED APPLICATIONS This application claims the priority of Japanese Patent Application No. 2007-225021 filed on Aug. 31, 2007, which is incorporated herein by reference. FIELD OF THE INVENTION The present invention relates to the pharmaceuticals useful for the treatment and prevention of the

TECHNICAL FIELD This invention generally relates to non-alpha-tocopherol compositions such as gamma-tocopherol, beta-tocopherol or delta-tocopherol, and/or metabolite(s) thereof, and methods for treating and/or ameliorating the symptoms of inflammation in a mammalian subject. The invention also

BACKGROUND OF THE INVENTION Cyclosporine is a metabolite isolated from the culture broths of the fungal species Tolypocladium inflatum Gams. A neutral, hydrophobic cyclic peptide composed of eleven amino acid residues, cyclosporine includes a previously unknown N-methylated amino acid composed of